Update on the neuroprotective effect of estrogen receptor alpha against Alzheimer's disease.

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by memory loss and disordered cognition. Women have a higher AD incidence than men, indicating that the declining estrogen levels during menopause may influence AD pathogenesis. However, the mechanism underlying estrogen's neuroprotective effect is not fully clarified and is complicated by the presence of several distinct estrogen receptor (ER) types and the identification of a growing number of ER splice variants. Thus, a deeper analysis of ERs could elucidate the role of estrogen in age-related cognitive changes. Intracellular calcium signaling cascades play a pivotal role in ERα neuroprotection against AD. The ERα-mediated inhibition of Death domain-associated protein (Daxx) translocation and the combination of membrane ERα and caveolin in caveolae may protect against AD. Moreover, the voltage-dependent anion channel (VDAC)/ERα association may be important for maintaining channel inactivation and may be relevant in neuronal preservation against Aβ injury. Additionally, ERα may prevent glutamate excitotoxic injury by Aβ through estrogen signaling mechanisms. ERα and IGF-IR co-activation may mediate neuroprotection, and many other growth factors and intracellular signaling responses triggered by ERα may also play important roles in this process. Furthermore, details regarding the genes and mRNA variants of ERα that are expressed in different parts of the human organs have been clarified recently. Therefore, here we review the literature to clarify the neuroprotective role of ERα. This review focuses on the potential mechanisms mediated by ERα in the intracellular signaling events in nervous system cells, thereby clarifying ERα-mediated protection against AD.

[1]  B. Sherwin.  Estrogen and memory in women: how can we reconcile the findings? , 2005, Hormones and Behavior.

[2]  Declan G. M. Murphy,et al.  Alzheimer's disease in women. , 2009, Best practice & research. Clinical obstetrics & gynaecology.

[3]  S. Lipton,et al.  Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss , 2013, Proceedings of the National Academy of Sciences.

[4]  A. Peri,et al.  Seladin-1 is a fundamental mediator of the neuroprotective effects of estrogen in human neuroblast long-term cell cultures. , 2008, Endocrinology.

[5]  A. Holmgren,et al.  Antioxidant function of thioredoxin and glutaredoxin systems. , 2000, Antioxidants & redox signaling.

[6]  J. Poirier,et al.  Increased caveolin-1 expression in Alzheimer’s disease brain , 2004, Neurobiology of Aging.

[7]  D. Swaab,et al.  Age-dependent ERα MB1 splice variant expression in discrete areas of the human brain , 2008, Neurobiology of Aging.

[8]  G. Casadesus,et al.  Gonadotropins: A cohesive gender-based etiology of Alzheimer disease , 2007, Molecular and Cellular Endocrinology.

[9]  Daniel R. Weinberger,et al.  Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia , 2008, Human molecular genetics.

[10]  T. Montine,et al.  Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial , 2011 .

[11]  Michael R. Hayden,et al.  Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin , 2009, Nature Medicine.

[12]  I. Harman-boehm,et al.  Effect of intranasal insulin on cognitive function: a systematic review. , 2012, The Journal of clinical endocrinology and metabolism.

[13]  F. Nicoletti,et al.  Estrogen Receptors and Type 1 Metabotropic Glutamate Receptors Are Interdependent in Protecting Cortical Neurons against β-Amyloid Toxicity , 2012, Molecular Pharmacology.

[14]  L. Thal,et al.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study , 2004, JAMA.

[15]  B. Winblad,et al.  Involvement of glutaredoxin-1 and thioredoxin-1 in β-amyloid toxicity and Alzheimer's disease , 2006, Cell Death and Differentiation.

[16]  C. Pike,et al.  Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease , 2011, Neurobiology of Aging.

[17]  I. Mook‐Jung,et al.  Diverse Molecular Targets for Therapeutic Strategies in Alzheimer's Disease , 2014, Journal of Korean medical science.

[18]  Shaomin Li,et al.  Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors , 2011, The Journal of Neuroscience.

[19]  Sterling C. Johnson,et al.  Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial. , 2011, Journal of Alzheimer's disease : JAD.

[20]  K. Ono,et al.  Estrogen has anti-amyloidogenic effects on Alzheimer's beta-amyloid fibrils in vitro. , 2007, Biochemical and biophysical research communications.

[21]  T. Duka,et al.  The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females , 2000, Psychopharmacology.

[22]  R. Brinton,et al.  Mitochondria as therapeutic targets of estrogen action in the central nervous system. , 2004, Current drug targets. CNS and neurological disorders.

[23]  G. Rune,et al.  Para/autocrine regulation of estrogen receptors in hippocampal neurons , 2003, Hippocampus.

[24]  Sanjay Asthana,et al.  Insulin dose–response effects on memory and plasma amyloid precursor protein in Alzheimer’s disease: interactions with apolipoprotein E genotype , 2003, Psychoneuroendocrinology.

[25]  Dick F. Swaab,et al.  Decreased alternative splicing of estrogen receptor-α mRNA in the Alzheimer's disease brain , 2012, Neurobiology of Aging.

[26]  S. Orrenius,et al.  Opening of plasma membrane voltage-dependent anion channels (VDAC) precedes caspase activation in neuronal apoptosis induced by toxic stimuli , 2005, Cell Death and Differentiation.

[27]  K. Ono,et al.  Effects of sex hormones on Alzheimer's disease-associated β-amyloid oligomer formation in vitro , 2011, Experimental Neurology.

[28]  D. Teplow,et al.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease. , 2008, Current pharmaceutical design.

[29]  C. Martínez-Campa,et al.  The Naturally Occurring Variant of Estrogen Receptor (ER) ERΔE7 Suppresses Estrogen-Dependent Transcriptional Activation by Both Wild-Type ERα and ERβ , 2003 .

[30]  P. Zandi,et al.  Hormone replacement therapy and incidence of Alzheimer disease in older women: The Cache County Study , 2003 .

[31]  Kyuwon Lee,et al.  GPR30 Regulates Glutamate Transporter GLT-1 Expression in Rat Primary Astrocytes* , 2012, The Journal of Biological Chemistry.

[32]  D. Swaab,et al.  Estrogen receptor alpha and its splice variants in the hippocampus in aging and Alzheimer's disease. , 2007, Neurobiology of aging.

[33]  P. Micevych,et al.  Membrane estradiol signaling in the brain , 2009, Frontiers in Neuroendocrinology.

[34]  C. Weickert,et al.  Transcriptional Interaction of an Estrogen Receptor Splice Variant and ErbB4 Suggests Convergence in Gene Susceptibility Pathways in Schizophrenia* , 2009, The Journal of Biological Chemistry.

[35]  A. Markou,et al.  Hormone replacement therapy in postmenopausal women. , 2005, Minerva endocrinologica.

[36]  Helgi B. Schiöth,et al.  Intranasal insulin as a therapeutic option in the treatment of cognitive impairments , 2011, Experimental Gerontology.

[37]  P. Mermelstein,et al.  Caveolin Proteins Are Essential for Distinct Effects of Membrane Estrogen Receptors in Neurons , 2007, The Journal of Neuroscience.

[38]  P. Micevych,et al.  Estradiol Rapidly Regulates Membrane Estrogen Receptor α Levels in Hypothalamic Neurons , 2010, The Journal of Neuroscience.

[39]  J. Boggs,et al.  Membrane‐associated estrogen receptor and caveolin‐1 are present in central nervous system myelin and oligodendrocyte plasma membranes , 2004, Journal of neuroscience research.

[40]  Richard L. Bowen,et al.  The gonadotropin connection in Alzheimer’s disease , 2005, Endocrine.

[41]  E. Salido,et al.  Voltage‐dependent anion channel as a resident protein of lipid rafts: post‐transductional regulation by estrogens and involvement in neuronal preservation against Alzheimer’s disease , 2011, Journal of neurochemistry.

[42]  Julie A. Harris,et al.  Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway. , 2002, Journal of neurochemistry.

[43]  Brenda L Plassman,et al.  Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. , 2002, JAMA.

[44]  A. Cedazo-Mínguez,et al.  Estrogen protects against amyloid-β toxicity by estrogen receptor α-mediated inhibition of Daxx translocation , 2012, Neuroscience Letters.

[45]  K. Frick.  Estrogens and age-related memory decline in rodents: What have we learned and where do we go from here? , 2009, Hormones and Behavior.

[46]  C. Ramírez,et al.  Voltage-dependent anion channel (VDAC) participates in amyloid beta-induced toxicity and interacts with plasma membrane estrogen receptor α in septal and hippocampal neurons , 2007, Molecular membrane biology.

[47]  Jeffrey R Bishop,et al.  A review of estrogen receptor &agr; gene (ESR1) polymorphisms, mood, and cognition , 2010, Menopause.

[48]  Roberta Diaz Brinton,et al.  Estrogen receptor α and β differentially regulate intracellular Ca2+ dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons , 2007, Brain Research.

[49]  Hyoung-Gon Lee,et al.  Down‐regulation of serum gonadotropins but not estrogen replacement improves cognition in aged‐ovariectomized 3xTg AD female mice , 2014, Journal of neurochemistry.

[50]  L. Garcia-Segura,et al.  Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain. , 2003, Brain research. Molecular brain research.

[51]  A. Belfiore,et al.  New advances on the functional cross-talk between insulin-like growth factor-I and estrogen signaling in cancer. , 2012, Cellular signalling.

[52]  P. Mermelstein.  Membrane‐Localised Oestrogen Receptor α and β Influence Neuronal Activity Through Activation of Metabotropic Glutamate Receptors , 2009, Journal of neuroendocrinology.

[53]  C. Pike,et al.  Protective actions of sex steroid hormones in Alzheimer’s disease , 2009, Frontiers in Neuroendocrinology.

[54]  G. Meyer,et al.  VDAC and ERα interaction in caveolae from human cortex is altered in Alzheimer's disease , 2009, Molecular and Cellular Neuroscience.

[55]  R. Brinton,et al.  17β-estradiol induced Ca2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: A potential initiation mechanism for estrogen-induced neuroprotection , 2005, Neuroscience.

[56]  Robert B Wallace,et al.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003, JAMA.

[57]  S. Hayashi,et al.  Estrogen signaling pathway and hormonal therapy , 2008, Breast cancer.

[58]  Xin-Min Li,et al.  Atypical antipsychotics attenuate neurotoxicity of β‐amyloid(25–35) by modulating Bax and Bcl‐Xl/s expression and localization , 2003, Journal of neuroscience research.

[59]  P. Maki.  Hormone therapy and cognitive function: Is there a critical period for benefit? , 2006, Neuroscience.

[60]  Ryan J. Haasl,et al.  Human neurons express type I GnRH receptor and respond to GnRH I by increasing luteinizing hormone expression. , 2006, The Journal of endocrinology.

[61]  Frank Z. Stanczyk,et al.  Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice , 2007, The Journal of Neuroscience.

[62]  Rena Li,et al.  Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[63]  M. Bennett,et al.  Insulin promotes rapid delivery of N-methyl-d- aspartate receptors to the cell surface by exocytosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[64]  D. Swaab,et al.  Estrogen receptor α and its splice variants in the hippocampus in aging and Alzheimer's disease , 2007, Neurobiology of Aging.

[65]  B. Liang,et al.  Estrogen receptor α gene polymorphisms and risk of Alzheimer’s disease: evidence from a meta-analysis , 2014, Clinical interventions in aging.

[66]  R. Ansbacher,et al.  The pharmacokinetics and efficacy of different estrogens are not equivalent. , 2001, American journal of obstetrics and gynecology.

[67]  D. Dorsa,et al.  Roles of estrogen receptors alpha and beta in sexually dimorphic neuroprotection against glutamate toxicity , 2010, Neuroscience.

[68]  J. Janowsky,et al.  Hot flashes and estrogen therapy do not influence cognition in early menopausal women , 2007, Menopause.

[69]  J. Xing,et al.  Neuroprotective effects of R,R-tetrahydrochrysene against glutamate-induced cell death through anti-excitotoxic and antioxidant actions involving estrogen receptor–dependent and –independent pathways , 2009, Neuroscience.

[70]  A. Harvey,et al.  Androgens and Alzheimer's disease , 2009, Current opinion in endocrinology, diabetes, and obesity.

[71]  T. Kageji,et al.  Activation of Estrogen Receptor-&agr; and of Angiotensin-Converting Enzyme 2 Suppresses Ischemic Brain Damage in Oophorectomized Rats , 2011, Hypertension.

[72]  R. Steiner,et al.  Regulation of Kiss1 and Dynorphin Gene Expression in the Murine Brain by Classical and Nonclassical Estrogen Receptor Pathways , 2009, The Journal of Neuroscience.

[73]  M. Hathaway,et al.  Roles of IGF-I and the estrogen, androgen and IGF-I receptors in estradiol-17beta- and trenbolone acetate-stimulated proliferation of cultured bovine satellite cells. , 2008, Domestic animal endocrinology.

[74]  Enhanced hepatic extraction of estrogens used for replacement therapy. , 1986, The Journal of clinical endocrinology and metabolism.

[75]  P. Mermelstein,et al.  Estrogen receptors stimulate brain region specific metabotropic glutamate receptors to rapidly initiate signal transduction pathways , 2011, Journal of Chemical Neuroanatomy.

[76]  A. McAllister,et al.  Estradiol Targets Synaptic Proteins to Induce Glutamatergic Synapse Formation in Cultured Hippocampal Neurons: Critical Role of Estrogen Receptor-α , 2007, The Journal of Neuroscience.

[77]  M. Ogiue-Ikeda,et al.  Estrogen synthesis in the brain—Role in synaptic plasticity and memory , 2008, Molecular and Cellular Endocrinology.

[78]  Dick F. Swaab,et al.  Changes in estrogen receptor-α and -β in the infundibular nucleus of the human hypothalamus are related to the occurrence of Alzheimer's disease neuropathology , 2004 .

[79]  F. Martin,et al.  Oestrogen receptor splice variants in the pathogenesis of disease. , 2010, Cancer letters.

[80]  Quan Gao,et al.  Involvement of IGF-I receptor and estrogen receptor pathways in the protective effects of ginsenoside Rg1 against Aβ25–35-induced toxicity in PC12 cells , 2013, Neurochemistry International.

[81]  Jie Zhou,et al.  Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions. , 2009, The American journal of pathology.

[82]  Andon Hestiantoro,et al.  Changes in estrogen receptor-alpha and -beta in the infundibular nucleus of the human hypothalamus are related to the occurrence of Alzheimer's disease neuropathology. , 2004, The Journal of clinical endocrinology and metabolism.

[83]  L. Mucke,et al.  Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks , 2010, Nature Neuroscience.

[84]  W. Dayton,et al.  Role of estrogen receptor-α (ESR1) and the type 1 insulin-like growth factor receptor (IGFR1) in estradiol-stimulated proliferation of cultured bovine satellite cells. , 2013, Domestic animal endocrinology.

[85]  D. Malaspina,et al.  Estrogen, estrogen treatment and the post-reproductive woman's brain. , 2007, Maturitas.

[86]  C. Ramírez,et al.  Modulation of Aβ-induced neurotoxicity by estrogen receptor alpha and other associated proteins in lipid rafts , 2008, Steroids.

[87]  B. Johnson,et al.  Potential role of G-protein-coupled receptor 30 (GPR30) in estradiol-17beta-stimulated IGF-I mRNA expression in bovine satellite cell cultures. , 2008, Domestic animal endocrinology.

[88]  B. Sherwin,et al.  Estrogen and cognitive aging in women. , 2002, Trends in pharmacological sciences.

[89]  G. Alton,et al.  Identification of a Structural Determinant , 2002 .

[90]  L. Garcia-Segura,et al.  Role of estrogen receptor α in membrane-initiated signaling in neural cells: Interaction with IGF-1 receptor , 2009, The Journal of Steroid Biochemistry and Molecular Biology.

[91]  Julie A. Harris,et al.  Estrogen‐mediated neuroprotection against β‐amyloid toxicity requires expression of estrogen receptor α or β and activation of the MAPK pathway , 2002 .

[92]  Sung-Chun Tang,et al.  Stroke Increases G Protein-Coupled Estrogen Receptor Expression in the Brain of Male but Not Female Mice , 2012, Neurosignals.

[93]  Leping Li,et al.  Estrogen-mediated Regulation of Igf1 Transcription and Uterine Growth Involves Direct Binding of Estrogen Receptor α to Estrogen-responsive Elements* , 2009, The Journal of Biological Chemistry.

[94]  H. Bading,et al.  Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders , 2010, Nature Reviews Neuroscience.

[95]  D. Bennett,et al.  Levels of estrogen receptors alpha and beta in frontal cortex of patients with Alzheimer's disease: relationship to Mini-Mental State Examination scores. , 2008, Current Alzheimer research.

[96]  Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study , 2004 .

[97]  A. Peri,et al.  Estrogen and selective estrogen receptor modulators exert neuroprotective effects and stimulate the expression of selective Alzheimer's disease indicator-1, a recently discovered antiapoptotic gene, in human neuroblast long-term cell cultures. , 2005, The Journal of clinical endocrinology and metabolism.

[98]  Yun S. Lee,et al.  Daxx is a key downstream component of receptor interacting protein kinase 3 mediating retinal ischemic cell death , 2013, FEBS letters.

[99]  P. Maki.  Minireview: effects of different HT formulations on cognition. , 2012, Endocrinology.

[100]  V. Chevaleyre,et al.  Estradiol rescues neurons from global ischemia-induced cell death: Multiple cellular pathways of neuroprotection , 2009, Steroids.

[101]  Jing Liu,et al.  RNA inference-mediated caveolin-1 down-regulation decrease estrogen receptor alpha (ERα) signaling in human mammary epithelial cells , 2011, Molecular Biology Reports.